Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1)
about
IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activationPtc1, a type 2C Ser/Thr phosphatase, inactivates the HOG pathway by dephosphorylating the mitogen-activated protein kinase Hog1Regulation of protein phosphorylation within the MKK1-ERK2 complex by MP1 and the MP1*P14 heterodimerA proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK functionp38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levelsGlobal quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex.Negative feedback regulation of the ERK1/2 MAPK pathwayFeedback regulation of beta-arrestin1 function by extracellular signal-regulated kinasesPAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activationInteraction of the Grb10 adapter protein with the Raf1 and MEK1 kinasesRegulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domainMitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion.Epidermal growth factor stimulates extracellular-signal regulated kinase phosphorylation of a novel site on cytoplasmic Dynein intermediate chain 2MEK1 activation by PAK: a novel mechanism.Endosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosisA novel tobacco mitogen-activated protein (MAP) kinase kinase, NtMEK1, activates the cell cycle-regulated p43Ntf6 MAP kinase.Development of anticancer drugs targeting the MAP kinase pathway.Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy.Regulation of ERK Kinase by MEK1 Kinase Inhibition in the BrainERK1/2 can feedback-regulate cellular MEK1/2 levels.MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1.MEK genomics in development and diseaseOncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.Heat stress activates fission yeast Spc1/StyI MAPK by a MEKK-independent mechanismThe ERK 1 and 2 pathway in the nervous system: from basic aspects to possible clinical applications in pain and visceral dysfunction.Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount.Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction.Epidermal growth factor and/or growth hormone induce differential, side-specific signal transduction protein phosphorylation in enterocytes.Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells.Activation of mitogen-activated protein kinases p42/44, p38, and stress-activated protein kinases in myelo-monocytic cells by Treponema lipoteichoic acid.The mammalian mitogen activated protein kinase network.Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells.Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase.Divergent effects of intrinsically active MEK variants on developmental Ras signaling.Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes.Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1.Quantitative relationship among integrin-ligand binding, adhesion, and signaling via focal adhesion kinase and extracellular signal-regulated kinase 2.Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.Fluorescence resonance energy transfer based quantitative analysis of feedforward and feedback loops in epidermal growth factor receptor signaling and the sensitivity to molecular targeting drugs.
P2860
Q24534869-42CDE0CB-094C-4240-AE5F-EB7505AD0C75Q24551035-D4F72C68-CC6D-4132-A95A-A7F55990E439Q24596060-CEB215FA-BC2E-4FD8-B2C8-32C1F1D76BB0Q24651242-3F7B5EDB-07B8-44D9-A3A5-6B4CB985CE97Q24682814-2100CB84-2129-420B-9481-C619CEEC4013Q27319445-88904BF8-F392-43A3-8B1B-CF365B53D9D0Q28079202-565B4400-BF21-4F28-A6F4-FF7747138D77Q28144769-D86741EA-E791-46F2-8731-0B041669CF33Q28188974-1F4B5E83-C14D-4A7D-80BE-840772132D40Q28268392-027F3248-46DE-4B48-B217-F026E0ABE972Q28506778-170F963D-4F38-4B9C-93B4-743492D9A67FQ30312140-9CA9AA8D-3B23-4645-B982-BCDAE688EA19Q30421931-F7D47326-04F7-4EA8-AF12-588846D0D8CCQ30441421-CEC1D26B-21A3-4BC0-8CF2-5030A2E73BFDQ30490506-C86135F2-E939-40CC-BA4B-C3460B3B7619Q30661587-8B27A1DC-84FD-4AA6-9FA0-C6D0A29B5FF3Q34293560-F1A0A2F5-C1A3-4DD0-AF51-8C96C929C9FDQ34973413-A488D48D-A2A6-460B-93F7-C2753FCF4FD3Q35783154-90EBC4DC-422A-42B9-8AA2-A85DF562A11AQ35967605-8CCF8FD0-0D0E-4365-9AC6-98CBE8892CF7Q36041862-0315863A-DED5-4610-BE18-A32A031289D9Q36099005-E0E46E40-7F74-4572-81F1-3CFDB8533083Q36394050-4A1D1AB2-733F-4302-B40B-C2158137BB44Q36873220-2C104ED2-6030-4263-BCFA-C161718EE1E1Q37420455-0C57BD4F-8190-42C2-8CBA-FB6EC076C089Q38086019-0CAEE39F-5A3A-49A3-8ED7-0BB2D746531AQ39630957-94230E9F-AF2D-4E29-AAFF-5CF59B0D4867Q40383991-CADE0348-D245-42C3-9093-B275AC44C219Q40565030-5E69A702-0B17-4EE9-BE67-AA0D309DA4B5Q40602929-90E220C6-55C9-4367-8204-6587223895BCQ40832428-D756A0D1-01A1-4525-B38F-076F2AAAA7C6Q40849045-CDC65985-CA2A-4A31-BE3E-4234656A35D6Q41109924-D57B240C-EFD4-4C61-9A6F-F23E94FDAD7DQ41115678-4D4AC907-F301-4823-B4A3-2C606FB25E95Q41412772-D0E901A6-DDE4-4600-9F66-E71865B7F4A3Q41955786-854B8EDF-AE82-459D-AF15-BF57854EF976Q42435242-128B5CDC-65A5-45BC-BD5A-398D3350C721Q42477319-E2C61257-0CB0-43A4-B234-B2EF96D78311Q44833697-246E9B0E-808B-443F-AB87-C015420C9283Q45715391-D927D698-6794-44D4-9AF1-6407EA48865C
P2860
Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1)
description
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1994
@ast
im Juni 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1994/06/13)
@sk
vědecký článek publikovaný v roce 1994
@cs
wetenschappelijk artikel (gepubliceerd op 1994/06/13)
@nl
наукова стаття, опублікована в червні 1994
@uk
مقالة علمية (نشرت في 13-6-1994)
@ar
name
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@ast
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@en
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@nl
type
label
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@ast
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@en
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@nl
prefLabel
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@ast
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@en
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@nl
P2093
P3181
P1433
P1476
Growth factor-stimulated MAP k ...... on of MAP kinase kinase (MEK1)
@en
P2093
J. Pouysségur
P304
P3181
P356
10.1016/0014-5793(94)00475-7
P407
P577
1994-06-13T00:00:00Z